# Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

Study · id `cardio:ct-nct04886388` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04886388](<https://clinicaltrials.gov/study/NCT04886388>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04886388

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 668 participants.

## Technical summary

Registry record NCT04886388. Randomized; no masking; primary purpose treatment. Start 2021-04-22 (actual); primary completion 2022-03-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 668 participants (enrolled count; ClinicalTrials.gov record NCT04886388, source copy `cardio:ctgov-nct04886388-2023-09-28`, retrieved 2026-10-26)
- Started: 2021-04-22 (actual) (ClinicalTrials.gov record NCT04886388, source copy `cardio:ctgov-nct04886388-2023-09-28`, retrieved 2026-10-26)
- Primary completion: 2022-03-09 (actual) (ClinicalTrials.gov record NCT04886388, source copy `cardio:ctgov-nct04886388-2023-09-28`, retrieved 2026-10-26)
- Completion: 2022-09-27 (actual) (ClinicalTrials.gov record NCT04886388, source copy `cardio:ctgov-nct04886388-2023-09-28`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04886388, source copy `cardio:ctgov-nct04886388-2023-09-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04886388-2023-09-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Device): BT-001
- Intervention (Other): Physician-guided Standard of Care for type 2 diabetes
- Lead sponsor: Better Therapeutics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 69899c39c4d3428a31260749dd42b1a54c64bec580577da88a674a5a9cf1cd2c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
